Here, a novel nanodrug consisting of H-ferritin nanoparticles loaded with Eve was developed, tested, and compared to free Eve for in vitro efficacy on sensitive and resistant BC cell lines used as in vitro models of HER2+, triple-negative, and ER+ BC. The gene discussed is FTH1; the disease is breast cancer.